Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients.

Source: von Storch, K., et al. 2019 - Pubmed ID: 31287736

Setting: Germany,

Study design:



Follow up: 3 months

Patient group:

Sample size:

Total: 2441 (115)

IG: 1541 (60)

CG: 900 (55)


Inclusion criteria:

  • Diabetes type 2
  • Age 40-67 years
Type of technology:

Home monitoring

  • Glucometer
  • Step counter
  • Data transfer (Tablet)
  •  Communication (Tablet)

Phone call

  • Guidance

Intervention: Tele medical devices served as a feedback tool for the patients to provide insight into the impact of behavior changes on their blood glucose levels. In each phone-based meeting, coach and participant developed and agreed on personal health goals that helped to better control the disease step by step. Phone calls at least every month.


Duration: 12 months
Add on: +


Control group: Care as usual

Clinical effect/ Patient safety:

Clinical effect:

  • HbA1c ↓
  • Diabetes self-management ↑
  • BMI ↓
  • Physical activity →

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences:  NA

Staff experiences: NA

Costs and organization:


  • Tablet
  • Glucometer

Staff resources

  • Telephone meeting


Health care utilization:

Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)